Top Headlines

Getty/Alfadanz

Mylan awaits US FDA rejection for GSK generic

Mylan says ‘minor deficiencies’ in its abbreviated new drug application for its proposed generic version of GSK’s Advair Diskus have prompted the US FDA to issue a complete response letter.

Global Industry News

Hot Topics

Spotlight

Follow us

Products

View more

Featured Suppliers

All suppliers